ARCHIVES

Benefit Seen In Novel Drug That Treats Gleevec Resistance

This article is from The Cancer Letter archive.

Vol. 28 No. 4 | April 29, 2005

Download PDF Visit The Full Archive

Related Articles

Possible Breach of Patient Confidentially By Calif. Physician; NCI

May 6, 1994

High Risk workshop Planned To Produce Monograph On Current Knowledge

October 11, 1974

FY2000 Appropriations: NIH Gets $17.9 Billion, A 15% Increase, In Final Budget Agreement; $3 billion to Be Delayed

November 26, 1999

20% of Women Do Not Believe Tailored Risk Assessments

August 30, 2013

Working Group To Review NCI Clinical Trials Programs

April 12, 1996

Firm Wins Patent For Method, Apparatus For Cryoablation.

December 15, 2000